Clinical trial

Immunomodulating Therapy and Improved Vaccination Responses by Cox-2 Inhibitor in HIV-infected Patients

NCT01269515

Study summary

ClinicalTrials.gov

Immunomodulating Therapy and Improved Vaccination Responses by Cox-2 Inhibitor in HIV-infected Patients

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Etoricoxib Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-10-01

PhasePHASE2

Conditions

HIVunresolved

Interventions

EtoricoxibDRUG

Sponsors & collaborators

Dag Kvalelead sponsor

The Research Council of Norwaycollaborator

Mapped research locations

OsloNorway2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01269515 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.